维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="CASHEN A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ study of lowdose deeitabine for the front-line treatment of older patients with acute myeloid leukemia(AML) 显示文摘	Cashen A Schiller GJ Larsen JS	2006	Blood2006，108，4：	1
2	Intracranial time-resolved con-trast-enhanced MR angiography at 3T显示文摘	Cashen T A Carr J C Shin W	2006	AJNR2006，27，5：	1
3	Phase Ⅱ study of the histone deacetylase inhibitor belinostat (PXD 101) for the treatment of myelodysplastic syndrome (MDS) 显示文摘	Cashen A Juckett M Jumonville A	2012	Ann Hematol2012，91，1：	1
4	Multicenter,phaseⅡstudy of decitabine for the first-line treatment of older patients with acute myeloid leukemia显示文摘	Cashen A F Schiller G J O’Donnell M R	2010	J Clin Oncol2010，128，4：	1
5	Phase II study of the histone deacetylase inhibitor belinostat(PXD101) for the treatment of myelodysplastic syndrome(MDS)显示文摘	CASHEN A JUCKETT M JUMONVILLE A	2012	Ann Hematol2012，91，1：	1
6	Phase lI study of the histone deacetylase inhibitor belinostat(PXD101) for the treatment of myelodys- plastic syndrome(MDS) 显示文摘	CASHEN A JUCKETT M JUMONVILLE A	2012	Ann Hematol2012，91，：	1
7	A phase 1 study of concomitant high-dose lenalidomide and 5-azaeitidine induction in the treatment of AML 显示文摘	Ramsingh G Westervelt P Cashen A	2013	Leukemia2013，27，3：	1
8	Phase Ⅱ study of low-dose decitabine for the front-line treatment of older patients with acute myeloid leukemia(AML)显示文摘	Cashen A Schiller GJ Larsen JS		0，，04：	1
9	Hydroxymethanesulfonic Acid as a Catalyst for Durable Press Finishing显示文摘	David R J Cashen N A Kullman R M H	1972	Textile Research Journal1972，42，2：	1
10	Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine显示文摘	CASHEN A F DEVINE H DIPERSIO J	2006	Am J Hematol2006，81，：	1
11	Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia显示文摘	Cashen A Schiller G J O' Donnell MR	2010	J Clin Oncol2010，18，：	1
12	Outcomes of allogeneic stem cell trans- plantation in hepatosplenic T-cell lymphoma 显示文摘	Rashidi A Cashen AF	2015	Blood Cancer J2015，5，6：	1
13	Multicenter,phase II study of decitabine for the first- line treatment of older patients with acute myeloid leuke- mia显示文摘	CASHEN A F SCHILLER G J O'DONNELL M R	2010	J Clin Oncol2010，28，：	1
14	Muhicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia显示文摘	Cashen A F Schiller G J O'Donnell M R	2010	J Clin Oncol2010，28，4：	1
15	Multicenter,phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia显示文摘	CASHEN A F SCHILLER G J O'DONNELL M R	2010	J Clin Oncol2010，28，4：	1
16	A phase I phamacokinetic trial of decitabine administered as a 3-hour infusion to patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS)显示文摘	Cashen A Shah A Helget A	2005	Blood2005，106，11：	1
17	Phase Ⅱ study of low-dose decitabine for the front-line treatment of older patients with acute myeloid leukemia (AML) 显示文摘	CASHEN A SCHILLER G J LARSEN J S	2006	Blood2006，108，56：	1
18	Phase II study of low- dose decitabine for the front line treatment of older patients with acute myeloid leukemia ( AML ) 显示文摘	Cashen A Schiller G Larsen JS	2006	Blood2006，108，：	1
19	Phase-study of low dose decitabine for the front linetreatment of older patients with acute myeloid leuke-mia(AML)显示文摘	CASHEN A SCHILLER G J LARSEN J S	2006	Blood2006，108，：	1
20	A phase I phamacokinetictrial of decitabine administered as a 3-hour infusion topatients with acute myelogenous leukemia(AML)ormyelodysplastic syndrome(MDS)显示文摘	Cashen A Shah A Helget A	2005	Blood2005，106，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示